BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36717864)

  • 1. What we don't need to prove but need to do in multidisciplinary treatment and care in Huntington's disease: a position paper.
    Mühlbӓck A; van Walsem M; Nance M; Arnesen A; Page K; Fisher A; van Kampen M; Nuzzi A; Limpert R; Fossmo HL; Cruickshank T; Veenhuizen R;
    Orphanet J Rare Dis; 2023 Jan; 18(1):19. PubMed ID: 36717864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Speech and language difficulties in Huntington's disease: A qualitative study of patients' and professional caregivers' experiences.
    Grimstvedt TN; Miller JU; van Walsem MR; Feragen KJB
    Int J Lang Commun Disord; 2021 Mar; 56(2):330-345. PubMed ID: 33577706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinated multidisciplinary care for ambulatory Huntington's disease patients. Evaluation of 18 months of implementation.
    Veenhuizen RB; Kootstra B; Vink W; Posthumus J; van Bekkum P; Zijlstra M; Dokter J
    Orphanet J Rare Dis; 2011 Nov; 6():77. PubMed ID: 22094174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinated multidisciplinary care for Huntington's disease. An outpatient department.
    Veenhuizen RB; Tibben A
    Brain Res Bull; 2009 Oct; 80(4-5):192-5. PubMed ID: 19576265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive care in Huntington's disease: a physician's perspective.
    Nance MA
    Brain Res Bull; 2007 Apr; 72(2-3):175-8. PubMed ID: 17352943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Australian Neuro-Palliative perspective on Huntington's disease: a case report.
    Shah R; Lee SC; Strasser RB; Grossman C
    BMC Palliat Care; 2021 Apr; 20(1):53. PubMed ID: 33794853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing the Value of Multidisciplinary Clinical Care in Huntington's Disease: A Snapshot of a New Huntington's Disease Center.
    Bardakjian TM; Klapper J; Carey A; Wood J; Pauly M; Gasper K; Lawler K; Tran B; Bell Y; Zwil A; Gonzalez-Alegre P
    J Huntingtons Dis; 2019; 8(4):501-507. PubMed ID: 31381522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntington's Disease Outpatient Clinic for Functional Diagnosis and Treatment: Coming to Consensus: How Long Term Care Facility Procedures Complement Specialist Diagnosis and Treatment.
    Veenhuizen R; Nijsten H; van Roosmalen P; Lammertsen K; Stor T; de Jager L; de Man J; van der Doelen R; Landa K; Grond V; Heffels J; Groenewoud R; Rovers L; Bakker C; Leiwakabessy S; van der Wedden D; van Blitterswijk J; van den Bosch D
    J Huntingtons Dis; 2018; 7(2):189-191. PubMed ID: 29843250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Guidelines for the Treatment of Huntington's Disease.
    Bachoud-Lévi AC; Ferreira J; Massart R; Youssov K; Rosser A; Busse M; Craufurd D; Reilmann R; De Michele G; Rae D; Squitieri F; Seppi K; Perrine C; Scherer-Gagou C; Audrey O; Verny C; Burgunder JM
    Front Neurol; 2019; 10():710. PubMed ID: 31333565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huntington's disease. Part 1: essential background and management.
    Aubeeluck A; Wilson E
    Br J Nurs; 2008 Feb 14-27; 17(3):146-51. PubMed ID: 18414253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs.
    Simpson JA; Lovecky D; Kogan J; Vetter LA; Yohrling GJ
    J Huntingtons Dis; 2016 Dec; 5(4):395-403. PubMed ID: 27983566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making a measurable difference in advanced Huntington disease care.
    Moskowitz CB; Rao AK
    Handb Clin Neurol; 2017; 144():183-196. PubMed ID: 28947117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late stage care in Huntington's disease.
    Simpson SA
    Brain Res Bull; 2007 Apr; 72(2-3):179-81. PubMed ID: 17352944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines on the diagnosis and management of the progressive ataxias.
    de Silva R; Greenfield J; Cook A; Bonney H; Vallortigara J; Hunt B; Giunti P
    Orphanet J Rare Dis; 2019 Feb; 14(1):51. PubMed ID: 30786918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health Care Delivery Practices in Huntington's Disease Specialty Clinics: An International Survey.
    Frich JC; Rae D; Roxburgh R; Miedzybrodzka ZH; Edmondson M; Pope EB; Goodman L; Haddad MS; Giuliano J; Nelson EC; Guttman M; Nance M
    J Huntingtons Dis; 2016 Jun; 5(2):207-13. PubMed ID: 27372053
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.